Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.
| Image |  |
|---|---|
| Description | scientific article published on 21 November 2017 |
| Author/s |
author: Jingqin Luo Matthew P Goetz |
| Publication date | November 21, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |